用18F-氟甘露醇PET在体内成像多种致病菌
本研究开发了新型放射性药物2-18F-氟-2-脱氧甘露醇(18F-氟甘露醇),体外和体内实验显示其可特异性蓄积于革兰阳性和革兰阴性细菌而不蓄积于哺乳动物细胞。在小鼠肌炎模型和撕裂伤口感染模型中,18F-氟甘露醇PET能区分无菌性炎症与金黄色葡萄球菌、大肠埃希菌感染,并快速特异检测多种重要病原体感染,还可监测万古霉素对金黄色葡萄球菌的体内疗效。
要点
- 18F-氟甘露醇在体外和体内特异性蓄积于革兰阳性和革兰阴性细菌,不蓄积于哺乳动物细胞。
- 18F-氟甘露醇PET可区分小鼠肌炎模型中的无菌性炎症与金黄色葡萄球菌、大肠埃希菌感染。
- 18F-氟甘露醇PET可监测万古霉素对金黄色葡萄球菌感染的体内疗效。
核心结论
- 18F-氟甘露醇易于生产,预期有利于放射性药物的广泛传播。
- 18F-氟甘露醇对体内细菌感染的广谱敏感性提示其是用于检测和监测感染、有望临床转化的理想显像剂,并值得在临床环境中进一步研究。
研究设计与样本
- 所有体外和体内研究使用的细菌临床分离株均连续取自战斗服役人员的伤口。
- 使用PET/CT对细菌感染进行体内定量,并切除感染组织以在体外确认放射性计数。
- 使用相同组织提取细菌,并将放射性计数与细菌菌落形成单位进行关联以确认细菌存在。
- 研究在小鼠肌炎模型和撕裂伤口模型中进行。
主要发现
- 18F-氟甘露醇在小鼠肌炎模型中用PET成像能够区分无菌性炎症与金黄色葡萄球菌及大肠埃希菌感染。
- 在感染鲍曼不动杆菌的撕裂伤口模型中,18F-氟甘露醇PET快速且特异地检测了鲍曼不动杆菌及其他几种重要病原体(粪肠球菌、金黄色葡萄球菌、肺炎克雷伯菌、鲍曼不动杆菌、铜绿假单胞菌和肠杆菌属)引起的感染。
- 18F-氟甘露醇PET能够监测万古霉素对金黄色葡萄球菌的体内治疗效果。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文结论指出值得在临床环境中进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Infectious disease remains the main cause of morbidity and mortality throughout the world. Of growing concern is the rising incidence of multidrug-resistant bacteria, derived from various selection pressures. Many of these bacterial infections are hospital-acquired and have prompted the Centers for Disease Control and Prevention in 2019 to reclassify several pathogens as urgent threats, its most perilous assignment. Consequently, there is an urgent need to improve the clinical management of bacterial infection via new methods to specifically identify bacteria and monitor antibiotic efficacy in vivo. In this work, we developed a novel radiopharmaceutical, 2-18F-fluoro-2-deoxy-mannitol (18F-fluoromannitol), which we found to specifically accumulate in both gram-positive and gram-negative bacteria but not in mammalian cells in vitro or in vivo. Methods: Clinical isolates of bacteria were serially obtained from wounds of combat service members for all in vitro and in vivo studies. Bacterial infection was quantified in vivo using PET/CT, and infected tissue was excised to confirm radioactivity counts ex vivo. We used these same tissues to confirm the presence of bacteria by extracting and correlating radioactive counts with colony-forming units of bacteria. Results: 18F-fluoromannitol was able to differentiate sterile inflammation from Staphylococcus aureus and Escherichia coli infections in vivo in a murine myositis model using PET imaging. Our study was extended to a laceration wound model infected with Acinetobacter baumannii, an important pathogen in the nosocomial and battlefield setting. 18F-fluoromannitol PET rapidly and specifically detected infections caused by A. baumannii and several other important pathogens (Enterococcus faecium, S. aureus, Klebsiella pneumoniae, A. baumannii, Pseudomonas aeruginosa, and Enterobacter spp.). Importantly, 18F-fluoromannitol PET was able to monitor the therapeutic efficacy of vancomycin against S. aureus in vivo. Conclusion: The ease of production of 18F-fluoromannitol is anticipated to facilitate wide radiopharmaceutical dissemination. Furthermore, the broad sensitivity of 18F-fluoromannitol for bacterial infection in vivo suggests that it is an ideal imaging agent for clinical translation to detect and monitor infections and warrants further studies in the clinical setting.
引用
- Simpson SR, Kesterson AE, Wilde JH, et al. Imaging Diverse Pathogenic Bacteria In Vivo with 18F-Fluoromannitol PET. J Nucl Med. 2022. PMID: 36522188. doi:10.2967/jnumed.122.264854
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。